A kind of compound and its preparation method and use

A compound and composition technology, applied in the field of medicine, can solve problems such as increasing the risk of thrombosis in patients

Active Publication Date: 2021-08-17
MICROPORT SINICA CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] Both of the above two drugs can inhibit the proliferation of smooth muscle cells, endothelial cells, fibroblasts, etc.; however, these two drugs still cannot fully meet the above-mentioned needs for preventing restenosis of blood vessels in the lesion after stent implantation, especially for intravascular The inhibition of different types of cell proliferation is not selective, that is, these two drugs have a strong inhibitory effect on smooth muscle cells, but also have a strong inhibitory effect on endothelial cells. The risk of thrombosis, leading to the need for patients to continue to take antithrombotic and platelet drugs for a long time after stent implantation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of compound and its preparation method and use
  • A kind of compound and its preparation method and use
  • A kind of compound and its preparation method and use

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0075] The preparation method of the medical device described in the present invention includes but not limited to:

[0076] Dissolving compound X in a solvent and coating it on the surface of the medical device by direct spraying, dipping or a combination of the two methods;

[0077] Or use electrostatic spraying or anodic polarization to spray or dip-coat the surface of the bracket. Soak for 48 hours to stop adsorption, and freeze-dry in a vacuum dryer at -55°C.

[0078] The solvent of the drug is alkanes, alkenes, alcohols, aldehydes, amines, esters, ethers, ketones, aromatic hydrocarbons, hydrogenated hydrocarbons, terpene hydrocarbons, halogenated hydrocarbons, heterocyclic compounds, nitrogen-containing compounds and sulfur-containing compounds, etc., preferably acetic acid Ethyl ester, n-propyl acetate, acetone, tetrahydrofuran, chloroform, dichloromethane.

[0079]The medical device described in the present invention can be one or more of medical devices such as hear...

Embodiment 1

[0091] Preparation of compound W

[0092]

[0093] A: NH 3 / MeOH heating back for 1h

[0094] B: Phosgene / THF

[0095] C: POCl 3 , Morpholine heated to reflux for 5h

[0096] D: 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, Pd(Pcy 3 ) 2 Cl 2 , CsF, NMP-water (9:1) 100℃48h

[0097] E: carbamoyl chloride, TEA, DCM reflux for 36h

[0098] The product was confirmed by LCMS, new peak Rf=15.754, M+=398.

Embodiment 2

[0100] Preparation of compound V

[0101]

[0102] A: NH 3 / MeOH heating back for 1h

[0103] B: Phosgene / THF

[0104] C: POCl 3 , Morpholine heated to reflux for 5h

[0105] D: 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, Pd(Pcy 3 ) 2 Cl 2 , CsF, NMP-water (9:1) 100℃48h

[0106] E:CH 3 COOOH / CH 3 COOH

[0107] The product was confirmed by LCMS, new peak Rf=12.013, M+=371.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a class of compounds with the structure of formula X or pharmaceutically acceptable salts thereof and their preparation methods and uses: wherein R1 is a chemical structure containing at least one five-membered ring or one six-membered ring; R2 is a compound with a molecular weight greater than 100 And contains the chemical structure of the electron-withdrawing group.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a compound that can be used for a drug stent and its preparation method and application. Background technique [0002] The intima of blood vessels is mainly composed of endothelial cells, and the media is mainly composed of smooth muscle cells and fibroblasts. After stent implantation, in order to prevent the restenosis of blood vessels in the lesion, it is hoped to inhibit the proliferation of smooth muscle cells to the lumen of the blood vessel to a relatively large extent; but in order to prevent the occurrence of thrombus, it is hoped that the lesion can be endothelialized as soon as possible, so it is not desirable The drug inhibits endothelial cells too strongly. [0003] At present, in clinical practice, drug stents are usually used to fight vascular restenosis, which requires that the drugs carried on the drug stents have less cytotoxicity, have good fat solubility, and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D239/48A61K31/5377A61K31/541A61P9/10A61P7/02A61F2/82A61M31/00
CPCA61F2/82A61M31/00A61M2210/12C07D239/48
Inventor 陈陆李俊菲胡燕王婷
Owner MICROPORT SINICA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products